Sanofi is said to be considering improving its $9.3 billion takeover offer for Medivation Inc. by agreeing to make future payments if Medivation meets certain targets, according to a Bloomberg article.
Sanofi executives reportedly met with Medivation investors to discuss the addition of contingent value rights as part of a potential improved bid for the company, said unnamed sources.
Representatives for Medivation and Sanofi declined to comment. Read the Bloomberg story